Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Arformoterol Tartrate Inhalation Solution Kumar Jeetendra | June 23, 2021 Mumbai, India, June 23, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA). Cipla’s Arformoterol …
